Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Jounce Therapeutics Inc
(NQ:
JNCE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jounce Therapeutics Inc
< Previous
1
2
3
Next >
Why Enovix Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
February 23, 2023
Gainers
Via
Benzinga
JNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Jounce Therapeutics, Inc. Is Fair to Shareholders
February 23, 2023
From
Halper Sadeh LLC
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 23, 2023
We're starting off the day with a look at all the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
Jounce Therapeutics Shares Fall After Disappointing Mid-Stage Lung Cancer Trial Data
August 30, 2022
Via
Benzinga
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday
January 03, 2023
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market...
Via
Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
December 28, 2022
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 28, 2022
Via
Benzinga
Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program
December 28, 2022
Via
Benzinga
Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today?
December 28, 2022
Gilead will try to win approval for what is now GS-1811, while Jounce develops other immunotherapy drugs. JNCE stock is soaring.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 28, 2022
Via
Benzinga
Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket
December 28, 2022
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners.
Via
Benzinga
Cal-Maine Foods, Kala Pharmaceuticals And 3 Stocks To Watch Heading Into Wednesday
December 28, 2022
With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
December 27, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 22, 2022
Via
Benzinga
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
December 15, 2022
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 13, 2022
On Tuesday, 49 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 05, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 15, 2022
On Tuesday, 34 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
November 11, 2022
Upgrades
Via
Benzinga
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81%
November 11, 2022
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to...
Via
Benzinga
Susquehanna Slashes Price Target On This Stock By 60%; Also Check Out Some Other Major PT Changes
August 31, 2022
Susquehanna cut the price target on Paysafe Limited (NYSE: PSFE) from $5 to $2. Susquehanna analyst James Friedman also downgraded the stock from Positive to Neutral. Paysafe shares fell 1.7% to $1.79...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
On Friday, 63 stocks hit new 52-week lows.
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 30, 2022
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
August 31, 2022
Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.
Via
Benzinga
Earnings Outlook For Jounce Therapeutics
August 03, 2022
Jounce Therapeutics (NASDAQ:JNCE) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Jounce...
Via
Benzinga
Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session
August 30, 2022
Gainers NewAge, Inc. (NASDAQ: NBEV) rose 54.4% to $0.3220.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
During the Thursday's session, 100 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.